To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.


Already Have an Account?

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:224 Issue:2 Number:1 ISSN#:2564-2537
ACE Report #14475
Ace Report Cover General Orthopaedics

The POISE-3 Trial: Tranexamic Acid in Patients Undergoing Noncardiac Surgery

How to Cite

OrthoEvidence. The POISE-3 Trial: Tranexamic Acid in Patients Undergoing Noncardiac Surgery. ACE Report. 2022;224(2):1. Available from:

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Tranexamic Acid in Patients Undergoing Noncardiac Surgery

N Engl J Med. 2022 Apr 2.

Contributing Authors:
PJ Devereaux M Marcucci TW Painter D Conen V Lomivotrov DI Sessler MTV Chan FK Borges MJ Martinez-Zapata CY Wang D Xavier SN Ofori M Wang S Efremov G Landoni YV Kleinlugtenbelt W Szczeklik D Schmartz AX Garg TG Short M Wittmann CS Meyhoff M Amir D Torres A Patel E Duceppe K Ruetzler JL Parlow V Tandon E Fleischmann CA Polanczyk A Lamy SV Astrakov WK Wu K Bhatt M de Nadal VV Likhvantsev P Paniagua HJ Aguado RP Whitlock MH McGillion M Prystajecky J Vincent J Eikelboom I Copland K Balasubramanian A Turan SI Bangdiwala D Stillo P Gross T Cafaro P Alfonsi PS Roshanov EP Belley-Côté J Spence T Richards T VanHelder W McIntyre G Guyatt S Yusuf K Leslie POISE-3 Investigators

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


9535 patients undergoing non-cardiac surgery were randomized to receive tranexamic acid (n=4757) or placebo (n=4778) at the start and end of surgery. The primary efficacy outcome was a composite bleeding outcome of life-threatening bleeding, major bleeding, or bleeding into a critical organ. The primary safety outcome was a composite endpoint of myocardial injury, non-hemorrhagic stroke, periphera...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.